US$ 28.36
glp 1 agonist and dementia Frontiers GLP-1 Receptor Agonists in Neurodegeneration:
Description
Researchers working with multiple peptides simultaneously should be particularly careful about labeling

GLP-1 series: What happens when you quit

C., Pancreatitis, Pancreatic, and Thyroid Cancer With GlucagonLike Peptide1Based Therapies, Gastroenterology 141 (2011): 150156

March 26, 2024
A comprehensive bibliometric analysis underscores emerging research directions in GLP-1RAs, such as investigations into novel agents (e.g., tirzepatide, semaglutide) in heart failure with preserved ejection fraction (HFpEF) and renal outcomes [48]
